Amgen Inc.
PROCESS FOR GENERATING GENETICALLY ENGINEERED AUTOLOGOUS T CELLS
Last updated:
Abstract:
The present invention relates to production of autologous genetically engineered T cells for use in cell therapy applications.
Status:
Application
Type:
Utility
Filling date:
15 Apr 2020
Issue date:
21 Oct 2021